BioPorto A/S (CPH:BIOPOR)
Denmark · Delayed Price · Currency is DKK 0.9240
-0.0160 (-1.70%)
Apr 15, 2026, 3:27 PM CET
BioPorto Revenue
In the year 2025, BioPorto had annual revenue of 40.29M DKK with 11.16% growth. BioPorto had revenue of 11.62M in the quarter ending December 31, 2025, with 47.18% growth.
Revenue
40.29M
Revenue Growth
+11.16%
P/S Ratio
11.55
Revenue / Employee
875.80K
Employees
46
Market Cap
465.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 40.29M | 4.04M | 11.16% |
| Dec 31, 2024 | 36.24M | 5.29M | 17.07% |
| Dec 31, 2023 | 30.96M | 1.99M | 6.87% |
| Dec 31, 2022 | 28.97M | 4.72M | 19.44% |
| Dec 31, 2021 | 24.25M | 1.05M | 4.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 309.06B |
| Coloplast | 27.89B |
| Genmab | 23.66B |
| ALK-Abelló | 6.31B |
| Gubra | 2.64B |
| ChemoMetec | 493.12M |
| Scandinavian Medical Solutions | 245.44M |
| ViroGates | 8.90M |
BioPorto News
- 14 days ago - BioPorto Advances U.S. Adult Urine NGAL Program with FDA Pre-Submission Request After Positive EPACRA AKI Cut Off Analysis - GlobeNewsWire
- 20 days ago - Notice convening the Annual General Meeting in BioPorto A/S - GlobeNewsWire
- 20 days ago - BioPorto announces the Annual Report for 2025 - GlobeNewsWire
- 27 days ago - BioPorto Successfully Completes Preliminary Analysis of U.S. Adult NGAL Cutoff Study; Pre-Submission expected by End of Q1 2026 - GlobeNewsWire
- 2 months ago - BioPorto provides Preliminary Unaudited 2025 Financial Figures, Financial Guidance for 2026 and a Business Update - GlobeNewsWire
- 5 months ago - BioPorto A/S raises approximately DKK 43 million in new capital round - Change in number of shares and votes - GlobeNewsWire
- 5 months ago - Private placement of 40,438,426 new shares fully subscribed – gross proceeds of approximately DKK 43 million to BioPorto A/S - GlobeNewsWire
- 5 months ago - BioPorto Executes on its Financing Strategy- BioPorto A/S initiates pre-subscribed private placement - GlobeNewsWire